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The flagellated protozoan Giardia duodenalis is a worldwide parasite causing giardiasis,
an acute and chronic diarrheal disease. Metabolism in G. duodenalis has a limited
complexity thus making metabolic enzymes ideal targets for drug development.
However, only few metabolic pathways (i.e., carbohydrates) have been described
so far. Recently, the parasite homolog of the mitochondrial-like glycerol-3-phosphate
dehydrogenase (gG3PD) has been identified among the interactors of the g14-3-
3 protein. G3PD is involved in glycolysis, electron transport, glycerophospholipids
metabolism, and hyperosmotic stress response, and is emerging as promising target in
tumor treatment. In this work, we demonstrate that gG3PD is a functional flavoenzyme
able to convert glycerol-3-phosphate into dihydroxyacetone phosphate and that its
activity and the intracellular glycerol level increase during encystation. Taking advantage
of co-immunoprecipitation assays and deletion mutants, we provide evidence that
gG3PD and g14-3-3 interact at the trophozoite stage, the intracellular localization
of gG3PD is stage dependent and it partially co-localizes with mitosomes during
cyst development. Finally, we demonstrate that the gG3PD activity is affected by
the antitumoral compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, that results
more effective in vitro at killing G. duodenalis trophozoites than the reference drug
metronidazole. Overall, our results highlight the involvement of gG3PD in processes
crucial for the parasite survival thus proposing this enzyme as target for novel antigiardial
interventions.
Keywords: Giardia duodenalis, FAD-dependent glycerol-3-phoshate dehydrogenase, 14-3-3 protein, energy
metabolism, mitosome, encystation, NBDHEX, nitroreduction
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Introduction
The ﬂagellated protozoan Giardia duodenalis (syn. lamblia,
intestinalis) is a parasite of the upper part of small intestine of
mammals, including humans. Infection withG. duodenalis causes
giardiasis, one of the most common foodborne and waterborne
gastroenteric diseases (Halliez and Buret, 2013; Ryan and Cacciò,
2013). The parasite has a simple two-stages life cycle consisting of
the trophozoite, that replicates and colonizes the host intestine
causing symptoms, and the cyst, the environmentally resistant
stage that is spread with feces and is responsible for transmission
of the infection. Generally, infection is acquired by ingestion of
cysts in contaminated water and food or by the fecal–oral route
(Ryan and Cacciò, 2013). Clinical symptoms of giardiasis can
vary from asymptomatic infection to acute and chronic diarrhea,
ultimately leading to chronic post-infectious gastrointestinal
complications, including irritable bowel syndrome and chronic
fatigue (Halliez and Buret, 2013). Up to date, no human
vaccine for giardiasis is available and treatment relies only on
a limited panel of eﬀective approved drugs. Nitroheterocyclics,
such as metronidazole (MTZ) and nitazoxanide (NTZ), are the
antigiardial drugs of choice. Unfortunately, treatment failure
has been reported in 10–20% of cases and strains resistant
to diﬀerent compounds have been either clinically isolated or
induced in vitro (Lalle, 2010; Watkins and Eckmann, 2014).
In this scenario, alternative, safe, and eﬀective therapies are
required.
Giardia duodenalis has a peculiar energy metabolism. It is a
microaerophilic organism that, instead of mitochondria, contains
mitosomes, highly reduced mitochondria-derived organelles
which sole function seems to be restricted to Fe-S cluster
biosynthesis (Tovar et al., 2003; Jedelský et al., 2011). Energy
is then generated by substrate level phosphorylation and
fermentation occurring in the cytoplasm or at the inner side
of the plasma membrane (Adam, 2001). In terms of sequence
similarity, these metabolic pathways of G. duodenalis consist of a
mixture of eukaryote-like and bacteria-like enzymes. Therefore,
energy and intermediate metabolism of G. duodenalis have
been shown to provide opportunities to identify novel and
eﬀective compounds, as well as potentially interesting targets
by means of high-throughput drug screening and target-based
drug design (Müller and Hemphill, 2013; Watkins and Eckmann,
2014).
We recently detected a putative glycerol-3-phosphate
dehydrogenase/ﬂavin-dependent oxidoreductase (gG3PD,
GL50803_16125) of G. duodenalis among proteins interacting
with the parasite 14-3-3 isoform, g14-3-3 (Lalle et al., 2012).
The 14-3-3s are a family of highly conserved eukaryotic
phosphoserine/phosphothreonine-binding proteins which
participate to the regulation of key cellular processes by
direct interaction with 100s of target proteins (Gardino and
Yaﬀe, 2011; Kleppe et al., 2011). The characterized g14-
3-3 interactome provides evidences that g14-3-3 can be
involved in parasite energy metabolism, as supported by the
identiﬁcation and conﬁrmation of components of both the
glycolytic/gluconeogenetic pathway and pyruvate metabolism
(Lalle et al., 2012).
Flavin adenine dinucleotide (FAD)-dependent glycerol-3-
phosphate dehydrogenase (G3PD, EC 1.1.5.3) is a key enzyme at
the crossroad of glycolysis, redox, and fatty acid metabolism, in
both prokaryotes and eukaryotes. G3PD catalyzes the oxidation
of glycerol-3-phosphate (G3P) to dihydroxyaceton phosphate
(DHAP) with simultaneous reduction of FAD to FADH2 and
transfer of electrons to quinones (e.g., ubiquinone; Unden and
Bongaerts, 1997; Mrácˇek et al., 2013). In eukaryotes, a single
subunit enzyme (mG3PD, 69–75 kDa) is strongly associated, as
peripheral protein, with the outer face of the inner mitochondrial
membrane (Janssen et al., 2002; Mrácˇek et al., 2013). The
mG3PD has multiple functions: (i) it forms the glycerophosphate
shuttle in combination with the cytosolic NADH-dependent
G3PD (cG3PD, EC 1.1.1.8) to re-oxidize the cytosolic NADH
produced by glycolysis; (ii) it is part of the mitochondrial
respiratory electron transport chain (ETC) channeling electron
to quinone pool and bypassing Complex I; (iii) it regulates the
cytosolic level of G3P (Bell and Coleman, 1980; Mrácˇek et al.,
2013). Prokaryotes harbor two distinct membrane-associated
FAD-dependent G3PDs, both necessary for bacterial growth
in presence of glycerol or G3P as sole carbon source, and
represent key primary dehydrogenases transferring reducing
equivalents to a short respiratory ETC with diﬀerent terminal
reductases and electron acceptor (O2, nitrate, or fumarate; Unden
and Bongaerts, 1997). The homodimeric GlpD is associated
with the cytoplasmic side of plasma membrane, shows 30–
33% homology with eukaryotic mG3PD, and is expressed under
aerobic conditions when O2 is the terminal acceptor (Walz et al.,
2002; Yeh et al., 2008). The heterotrimeric GlpACB is induced
under anaerobic conditions, with fumarate as terminal acceptor
(Cole et al., 1988; Varga andWeiner, 1995): it forms a functional-
associated complex with fumarate reductase and contributes to
generate a proton gradient across the membrane via an associated
ETC (Miki and Wilson, 1978). The GlpAC heterodimer (62 and
41 kDa, respectively) is the soluble catalytic subunit, containing
the FAD and FMN binding sites (Cole et al., 1988). The GlpB
(44 kDa) subunit, that contains a ferredoxin-type (4Fe-4S) cluster
binding motif, anchors the GlpAC dimer to the inner cytoplasmic
membrane and mediate the transfer of reducing equivalent to the
menaquinone pool and ﬁnally to the fumarate reductase (Varga
and Weiner, 1995).
The G3PDs are also involved in pathogenicity as a source of
reactive oxygen species (ROS). The mG3PD has been implied in
the establishment of a pro-oxidative environment that promotes
the fast growth of undiﬀerentiated tumors (Chowdhury et al.,
2007; Mrácˇek et al., 2013), whereas the oxidase activity of GlpD of
Mycoplasma sp. seems to be crucial for the pathogenicity, leading
to high levels of H2O2, and host cell damage (Großhennig et al.,
2013).
In the present work, we investigated gG3PD expression,
activity, and cellular localization in the G. duodenalis trophozoite
stage and during the encystation process. Moreover, we
demonstrated that the antitumoral compound [NBDHEX, 6-
(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol] is an eﬀective
antigiardial compound that negatively aﬀected gG3PD activity.
Overall, our results pointed out the role of gG3PD in biological
processes crucial for the parasite survival, thus suggesting that
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this enzyme could represent a good candidate for targeted
antigiardial interventions.
Materials and Methods
Chemicals
The NBDHEX was synthetized as previously described (Ricci
et al., 2005). MTZ, FAD disodium salt, sn-g3p, phenazine
methosulfate (PMS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylt
etrazolium bromide (MTT) were from Sigma–Aldrich (St. Louis,
MO, USA).
Parasite Cultivation, Differentiation, and
Transfection
The G. duodenalis isolate WB clone C6 (WB-C6) was axenically
grown in TYI-S-33 medium at 37◦C and diﬀerentiation into
cyst (encystation) was induced in TYI-S-33 medium containing
5 mg/ml of bovine bile at pH 7.8 for the indicated time (Schupp
et al., 1988). Parasites were collected by chilling tubes on ice
and centrifugation at 800 × g. Transgenic lines were generated
by trophozoite electroporation with 15 μg of plasmid DNA and
selected and maintained under constant selection with 100 μM
puromycin (Invivogen, Toulouse, France).
Vector Construction
Escherichia coli BL21-DE3 competent cells were used. The full-
length sequence of gG3PD (accession number GL50803_16125),
the gG3PD N-terminal (nucleotide 3-1590; gG3PD_N), and
the C-terminal half (nucleotide 1569-3333; gG3PD_C), were
PCR ampliﬁed from the G. duodenalis WB-C6 genomic DNA,
prepared as previously described (Lalle et al., 2012). The primers
used and their combinations are reported in Table 1. Reactions
were performed on a T-Personal Thermocycler (Biometra,
Göttingen, Germany) using 100 ng of gDNA, 10 units of high
ﬁdelity Pfu turbo DNA polymerase (Agilent Technologies, Santa
Clara, CA, USA), 50 μM dNTP, 20 pmols of each primer in
50 μl of reaction mixture. Ampliﬁcation conditions were: 1
cycle at 95◦C for 2 min; 30 cycles at 95◦C for 30 s, 58◦C for
30 s, and 72◦C for 30 s; and 1 cycle at 72◦C for 7 min. PCR
fragments were cloned either in the BamHI/PspOMI digested
pTUB-FLAG_HApac vector (Lalle et al., 2012) for expression
in G. duodenalis, or in the BamHI/NotI digested pQ30 vector
(Qiagen, Germany) for expression in bacteria as N-terminal
6xHIS-tagged fusion protein.
Expression and Purification of the
Recombinant Proteins
Transformed E. coli were grown in SOB medium and
recombinant proteins expression was induced at OD600 = 0.6,
with 0.5 mM isopropyl-thio-β-D-galactoside at 37◦C for 4 h.
All 6xHIS-fused proteins were puriﬁed under native condition
by aﬃnity chromatography on nickel resin (Qiagen) and eluted
with 250 mM imidazole (pH 8.0). Proteins were dialyzed against
PBS (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM
KH2PO4, pH 7.4) using Slide-A-Lyzer dialysis cassettes (cut-
oﬀ 3.5 kDa, Thermo Fisher Scientiﬁc, Rockford, IL, USA).
The protein concentration was determined by Bradford assay
(Thermo Fisher Scientiﬁc) and proteins were stored at −70◦C
until use.
Production of Polyclonal Antibodies
Puriﬁed HIS-gG3PD fusion protein was used to immunize
intraperitoneally two BALB/c mice (Charles River Laboratories
International, Inc., Wilmington, MA, USA) on days 0, 21, and
42 with 50 μg protein in 300 μl of emulsiﬁed 1:1 PBS/Freund’s
complete adjuvant (Sigma–Aldrich; at day 0) or 1:1 PBS/Freund’s
incomplete adjuvant (Sigma–Aldrich; at day 21) or without any
adjuvant (at day 42). Blood was collected from the tail vein before
initial immunization and after each boost. Sera fractions were
assayed for speciﬁc antibody content.
Preparation of G. duodenalis Proteins
Total soluble proteins (S) and octyl β-D-glucopyranoside
solubilized proteins from membranous material (M) were
prepared as previously described (Lalle et al., 2012) starting
from 2 × 109 trophozoites or encysting parasites. The protein
concentration was determined by Bradford methods (Thermo
Fisher Scientiﬁc) and the protein lysates were stored at
−70◦C. Alternatively, to assess the G3PD enzymatic activity in
G. duodenalis, 106 parasites were collected, washed two times
with cold PBS, suspended in 200 μl of PBS/1% TritonX100
and incubated 1 h on ice. After centrifugation at 13.000 × g
for 15 min, supernatant was collected, protein concentration
quantiﬁed by Bradford methods and the preparation was
immediately used for the enzymatic assay as detailed below.
Western Blot Analysis
Proteins were separated on SDS-PAGE and transferred onto
PVDF membrane with 39 mM glycine, 48 mM Tris, 0.1% SDS,
TABLE 1 | Primer list.
Target Forward primera Reverse primerb
Full length glycerol-3-phosphate
dehydrogenase (gG3PD)
gG3PDforw
5′-GGATCCACCACCGCTCACCCTTTACC-3′
gG3PDrev
5′-GCGGCCGCTCACTTCATAGCCGGAATGTTC-3′
N-terminal gG3PD gG3PDforw NTrev
5′-GCGGCCGCTCAGTATGCCTTGTCCATCGGGGTG-3′
C-terminal gG3PD CTforw
5′-GGATCCACCCCGATGGACAAGGCATAC-3′
gG3PDrev
aThe BamHI site is underlined.
bThe NotI site is underlined.
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and 10%methanol, using a semidry apparatus (BioRad, Hercules,
CA, USA). Membranes were blocked with 5% skin milk in TTBS
(20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.05% Tween 20) for
1 h and then incubated with the primary antibody (Ab) in 2.5%
skin milk/TTBS buﬀer. After incubation with an appropriate
HRP-conjugated secondary Ab (1:3000), the interaction was
revealed by chemiluminescence (Millipore, France). Antibodies
were used at the following dilution: mouse polyclonal anti-
gG3PD antiserum 1:3000; mouse anti-HA mAb (Sigma–Aldrich)
1:3000; rabbit N14 (anti-g14-3-3) antiserum (Lalle et al., 2006)
1:5000; mouse anti-αTubulin (Sigma–Aldrich) 1:10000; rabbit
anti-gPGN (phosphoacetylglucosamine mutase, Lopez et al.,
2003) 1:1000; mouse anti-HIS mAb (Qiagen) 1:2000.
Blue Native PAGE (BN-PAGE)
Three to twelve percentage of BN-PAGE (Invitrogen, Carlsbad,
CA, USA) was carried out using 1 μg of puriﬁed HIS-
tagged recombinant proteins according to the manufacturer.
This technique allows the separation of very high molecular
weight multiprotein complexes. Gels were run in Running buﬀer
(0.002% Coomassie G-250, 50 mM BisTris/50 mM Tricine, pH
6.8) at 150 V for approximately 2 h. Gels were incubated in
Tris/glycine/SDS buﬀer for 30 min and either stained with a
Silver Staining kit (Invitrogen) or processed for western blot as
described.
Affinity Purification
FLAG-tagged proteins were puriﬁed by aﬃnity chromatography
onmouse anti-FLAGM2mAb covalently bound to agarose beads
(Sigma–Aldrich) as previously reported (Lalle et al., 2012) and
directly eluted from the resin by incubation with 200 μM FLAG-
peptide at 4◦C for 1 h. The eluted materials were stored at −70◦C
until use.
Confocal Laser Scanning Microscopy (CLSM)
Trophozoites or encysting parasites were ﬁxed and permeabilized
as previously described (Lalle et al., 2006). Antibodies were used
at the following dilution: polyclonal rabbit N14 antiserum
1:50; mouse polyclonal anti-gG3PD antiserum 1:50; polyclonal
rabbit anti-gTom40 antiserum (Dagley et al., 2009) 1:50,
FITC-conjugated mouse anti-HA mAb (Miltenyi Biotec,
Germany) 1:50; Cy5-conjugated anti-CWP mAb (Waterborne
Inc., New Orleans, LA, USA) 1:30. Alexa-Fluor 647- and
488-conjugated anti-rabbit and anti-mouse secondary Ab
(Invitrogen) were used at a 1:500 dilution. After parasite staining,
coverslips were extensively rinsed and then mounted using
Vectashield
R© mounting medium (Vector Laboratories Inc.,
Burlingame, CA, USA) containing 300 nM of 4′,6-diamidino-
2-phenylindole (DAPI). Confocal laser scanning microscopy
(CLSM) observations were performed on a Leica TCS SP2 AOBS
(Leica Microsystems, Germany) apparatus, using excitation
spectral laser lines at 405, 488, and 647 nm and selecting
emission wavelengths by a proper setting of the spectral
detection system. Signals from diﬀerent ﬂuorescent probes were
taken in sequential scan mode. Image acquisition and processing
were conducted using the Leica Confocal Software (Leica
Microsystems). Image deconvolution was performed using the
Huygens software (Scientiﬁc Volume Imaging BV, Hilversum,
The Netherlands). Data were inferred from two independent
experiments following the analysis of diﬀerent ﬁelds of view
(>200 cells) on the microscope for each labeling condition.
G3PD Enzymatic Assay, Spectrophotometric,
and Fluorimetric Analysis
The dehydrogenase activity of gG3PD was assayed
spectrophotometrically according to Kistler and Lin (1972)
measuring the rate of PMS-mediated reduction of the tetrazolium
dye, MTT, to its formazan by addition of g3p. Reactions were
performed in 96 well plate using either 100 μg of G. duodenalis
Triton X-100 protein lysate or 16 pmol of puriﬁed recombinant
HIS-tagged proteins in a ﬁnal volume of 200 μl containing
67 mM of potassium phosphate (pH 7.5), 0.2% Triton X100,
6.6 μg of MTT, 20 μg of PMS, and 17 mM of g3p with or
without 10 μM FAD. The g3p was omitted in the blank. Since
crude extracts could contain substantial endogenous substrates,
to ensure a linear rate of MTT reduction, reactions were
pre-incubated at 25◦C for 5 min prior to the addition of MTT
and g3p. Plates were sealed with an air-tight adhesive tape
(Greiner Bio One, Austria) to prevent evaporation. After blank
subtraction, the enzyme activity was calculated and expressed as
micromoles per minute per milligram of protein, considering
that the extinction coeﬃcient of reducedMTT is 17mM−10cm−1
a 570 nm. UV-visible spectra of HIS-gG3PD (10μg/μl) in 67mM
of potassium phosphate (pH 7.5), were recorded at 25◦C in 10 μl
quartz capillaries. UV-visible spectra of 100 μM NBDHEX were
recorded in 67 mM of potassium phosphate (pH 7.5), 17 mM
of g3p, with or without HIS-gG3PD (42 pmol) in 0.5 ml quartz
cuvette. All measures were done at 25◦C in aMultiskan Spectrum
(Thermo) spectrophotometer. Fluorescent spectra (excitation at
430 nm) were acquired in a Luminescence Spectrometer LS50B
(Perkin–Elmer, Waltham, MA, USA).
Determination of Intracellular Glycerol
For the assay, 106 parasites were collected as previously described,
suspended in 100 μl of PBS, incubated 10 min at 95◦C and
the supernatant collected after centrifugation at 12,000 × g for
1 min. Protein concentration was measured by Bradford assay.
Intracellular glycerol level was enzymatically determined using
the Free Glycerol Reagent kit (Sigma–Aldrich) by measuring
spectrophotometrically the production of a quinoneimine dye
at 540 nm. Assay was performed on 96 well-plate according
to the manufacturer’s instruction, using 40 μl of parasite
lysate and 160 μl of enzyme mixture per well. After 5 min
of incubation at 37◦C, absorbance was read by Multiskan
Spectrum (Thermo Scientiﬁc) spectrophotometer. Intracellular
glycerol concentration was calculated interpolating the obtained
absorbance with a glycerol standard curve and expressed as pmol
of glycerol/μg of total protein. Each condition was assayed in
triplicate and the experiment was performed independently three
times.
In Vitro Drug Susceptibility Assay
The in vitro assays were performed according to Bénéré
et al. (2007) and Hounkong et al. (2011) with modiﬁcations.
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All compounds were dissolved and serially diluted in 1:1vol
ethanol/DMSO. G. duodenalis trophozoites (5× 105 parasite/ml)
were cultured in 96-well plates (Nunc  surface, Thermo
Scientiﬁc) in TYIS-33 medium and 3 μl of 100X concentrated
compound, or solvent, were added to reach the desired
compound concentration. The plates were sealed with an air-
tight adhesive tape (Greiner Bio-One GmbH, Austria) and
incubated for 48 h at 37◦C. After the incubation period,
culture medium was removed. Adherent trophozoites were
immediately ﬁxed with 300 μl of methanol for 2 min and
then stained with a solution of 0.1% methylene blue in PBS
for 10 min at RT. Wells were washed three times with PBS
and incubated with 200 μl of ethanol and 0.1 M HCI [1:1
(v/v) in H2O], to elute the dye. Absorbance was determined at
655 nm by Multiskan Spectrum (Thermo Scientiﬁc) microplate
spectrophotometer. Growth inhibition was calculated as the
percentage of treated parasite in comparison with untreated
parasite. Three independent experiments were performed and
each drug dilution was assayed in triplicate. Alternatively,
for drug eﬃcacy tests with resazurin (Bénéré et al., 2007),
trophozoites were grown in the presence of serial dilutions of
the drugs, or DMSO as control, in an anaerobic growth chamber
(100% N2, 37◦C). After 72 h, the medium was removed, the wells
were washed three times with pre-warmed PBS containing 1% of
glucose (0.2 ml per well), and ﬁnally, 0.2 ml PBS with glucose
containing 10 mg/l resazurin were added. Reduced resazurin
was quantiﬁed by ﬂuorimetry (excitation at 365 nm, emission
at 455 nm) using a 96-well-multimode plate reader Enspire
(Perkin–Elmer).
For immunolocalization and enzymatic assays, drug
treatments were performed in 10 ml screw cap tubes using
1 × 105 parasite/ml of G. duodenalis trophozoites. Twenty ﬁve
microliter of 20 mM NBDHEX in ethanol, or the equal volume
of ethanol, was added to 10 ml of TYS-I-33 medium (ﬁnal
concentration 50 μM) and parasites were incubated at 37◦C for
the indicated time periods and cells were processed as described
in previous paragraphs.
Mass Spectrometry Analysis
Proteins were separated on a 1D-gel NuPAGE 4-12%
(Novex, Invitrogen) run in morpholinepropanesulfonic
acid (MOPS) buﬀer and stained with the Colloidal Blue
Staining kit (Invitrogen). Slices were excised and digested with
modiﬁed sequencing-grade trypsin (Promega Corporation,
France), as previously described (Shevchenko et al., 1996).
Nanoﬂow reversed-phase liquid chromatography tandem mass
spectrometry (RP-LC-MS/MS) analysis of peptide mixtures
was performed using an HPLC Ultimate 3000 (DIONEX,
Sunnyvale, CA, USA) coupled with a linear ion trap (LTQ,
Thermo Electron, San Jose, CA, USA) mass spectrometer.
Peptides were desalted in a trap column (Acclaim PepMap 100
C18, LC Packings, DIONEX) and separated in the analytical
column, a 10 cm long fused silica capillary (Silica Tips FS
360-75-8, New Objective) in house slurry-packed with a 5 μm,
200 Å pore size C18 resin (Michrom BioResources, Auburn,
CA, USA). Peptides were eluted using a 40 min linear gradient
from 96% aqueous buﬀer containing 5% acetonitrile and 0.1%
formic acid to 60% organic buﬀer constituted by acetonitrile
with 5% H2O and 0.1% formic acid, at 300 nL/min ﬂow rate.
Analyses were performed in positive ion mode and the HV
Potential was set up around 1.7–1.8 kV. Tandem mass spectra
were matched against the G. duodenalis protein database
(Giardia DB version 1.2) downloaded from the Web site
http://www.giardiadb.org/giardiadb and through the SEQUEST
algorithm incorporated in the Bioworks software (version
3.3, Thermo Electron). The following match parameters were
considered: fully tryptic cleavage constraints (one miscleavage
allowed), static cysteine carbamidomethylation, and variable
methionine oxidation. Precursor and fragment ions were
searched with 1.5 and 1 Da tolerance, respectively. Possible
NBDHEX adducts on cysteine or lysine residues were searched.
The mass increments considered were +296, +281, +265 Da,
for the intact, partially or completely nitro-reduced NBDHEX
adducts, respectively. Statistical parameters used for legitimate
protein identiﬁcation were described elsewhere (Lalle et al.,
2012).
Chemical Reduction of NBDHEX
Sodium dithionite was prepared as a 1M solution in ddH2O
and was used 100 mM to chemically reduce 10 mM NBDHEX
in 20 μl 0.5% NH3. After 5 min, 2 μl reaction was diluted
to 200 μl in 67 mM potassium phosphate buﬀer (pH 7.5).
NBDHEX ﬂuorescence quenching was veriﬁed at 25◦C in a
Luminescence Spectrometer LS50B (Perkin–Elmer) whereas the
UV-visible spectra was acquired at 25◦C in a Multiskan Spectrum
(Thermo Scientiﬁc) spectrophotometer in 0.5 ml quartz cuvettes.
For the mass spectrometry analysis, the reaction mixture was
diluted in 50% ethanol and 1% ammonia and directly infused in
the LTQ mass spectrometer through a glass tip. The nanospray
ionization in positive ion mode was allowed applying 1.5–1.6 kV.
HV Potential. Full MS in the 150–350 m/z range were acquired;
then MS3 fragmentation of the ions 280 and 250, derived from
MS2 of 298 and 268, respectively, was induced.
Sequence Analysis
Conserved functional domains and sites in the protein sequence
were search using ELM (Dinkel et al., 2014) and BLASTP1
algorithms. Transmembrane (TM) regions were search by
TMHMM Server v.2.02. Mitochondrial targeting signal were
search using Psort II3 and MitoProt II4. Genomic sequences of
1133 organisms were downloaded from EggNog database v.3.0
(Powell et al., 2012). If more than one strain was available,
only the strain classiﬁed as “core” was retained. This selection
resulted in 774 organisms, which were included in the reference
set. The Smith–Waterman algorithm available in the FASTA
package (Pearson and Lipman, 1988) was exploited using as
query the gG3PD full-length sequence, or the protein portions
encompassing: the ﬁrst 500 residues (referred as N-terminal
domain); or the residues 501–950 (referred as central domain); or
1http://blast.ncbi.nlm.nih.gov
2http://www.cbs.dtu.dk/services/TMHMM/
3http://psort.hgc.jp/form2.html
4http://ihg.gsf.de/ihg/mitoprot.html
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the residues 951–1111 (referred as the C-terminal domain); or the
protein portion including the N- and central domains (residues
1–950). Sequences having a match result with E-value lower
than 10−6 were selected, except for the C-terminal domain for
which the E-value threshold was set at 10−3. Sequence analysis,
editing and phylogenetic analysis were performed using Bioedit
(Hall, 1999), MEGA 5.0 (Tamura et al., 2013), and Jalview 2.8.2
(Waterhouse et al., 2009).
Statistics
Statistical analyses were performed with PRISM 6.0 software
(GraphPad Software, Inc; La Jolla, CA, USA) and signiﬁcance
was calculated by Student unpaired t-test and one-way ANOVA.
A P-value <0.05 was considered statistically relevant.
Results
Sequence Analysis of the Putative FAD-D
glycerol-3-Phosphate Dehydrogenase (gG3PD)
of G. duodenalis Reveals an Unusual Protein
Organization
The GL50803_16125 entry encodes a protein of 1111
amino acids (∼119 kDa) annotated as FAD-dependent
oxidoreductase/glycerol-3-phosphate dehydrogenase, that
we named gG3PD. A combined search for conserved regions in
the gG3PD protein sequence retrieved three principal domains
(Supplementary Figure S1A). The region encompassing residues
31–510 contains the multidomain TIGR03377 corresponding to
the protein family of the subunit A (GlpA) of anaerobic GlpACB.
A second domain, residues 587–910, corresponds to a small
NADH binding domain within a larger FAD binding domain
(Pyr_redox_2, PF07992) which is common to ﬂavoproteins
of the pyridine nucleotide-disulphide oxidoreductases family
[e.g., thioredoxin reductases (TRxR), NADH oxidases, and
peroxidases]. The last domain (DUF 1667), encompassing
residues 1039–1103, was previously found in archaeal and
bacterial hypothetical proteins, some of which are annotated
as being potential metal-binding proteins. As for other G3PDs,
no TM regions could be detected. Due to its unusual domain
organization, the full-length or three portions (residues 1–
510, 511–950, and 951–111) of the gG3PD protein sequence
were used as query against a large non-redundant set of high
quality reference genomes obtained from EggNog. Despite
an homologous sequence present in the genome of the
closely related diplomonad Spironucleus salmonicida, only
protozoan parasites of the genus Entamoeba encode for a
single sequence orthologous to the full length gG3PD and
also annotated as glycerol-3-phosphate dehydrogenase. One
orthologue of the ﬁrst two portions of the gG3PD was found
in the genomes of Eggerthella sp., a non-sporulating medically
important anaerobic Gram-positive bacillus, and annotated
as FAD-dependent oxidoreductase. On the contrary several
hundred orthologues of the ﬁrst portion of gG3PD (residues
1–510), all annotated as glycerol-3-phosphate-dehydrogenases,
were found in the genome of human and animal pathogenic
bacteria, such as Treponema sp. (Spirochaetes) and Clostridium
sp. (Firmicutes), or to halophilic archaea, e.g., Halorhabdus
utahensis, (Supplementary Figure S1B). More than 100
orthologues of the second portion (residues 501–950) were
found in human and animal pathogenic bacteria, but also in soil
and plant bacteria (data not shown). Although several of these
proteins were annotated as oxidoreductases it was not possible
to deﬁne, in terms of substrate or biochemical pathway, any
speciﬁc enzymatic function. Finally, only 33 orthologues were
found respect to the third portion of gG3PD (residues 951–
111), which putative function could be that of metal-binding
proteins.
The Intracellular Localization and Stage
Expression of gG3PD Protein
According to the data reported in GiardiaDB, the expression
level of the gg3pd is downregulated during encystation. To
investigate whether the gG3PD protein expression level was
similarly regulated we used a mouse polyclonal antibody raised
against a full-length HIS-tagged recombinant gG3PD expressed
in bacteria. As shown in Figure 1A, a band of approximately
120 kDa was immunodecorated with comparable intensity by the
anti-gG3PD Ab, both in cellular lysates from trophozoites and
from parasites harvested at diﬀerent time points after encystation
induction (at 6, 12, and 24 h). Encystation progress was checked
by immunostaining with anti-phosphoacetylglucosamine mutase
(gPGN) Ab, a protein induced during cyst formation (Lopez
et al., 2003). The anti-gG3PD Ab was also used to study
the intracellular localization of the protein by CLSM. In the
trophozoite (Figure 1Ba) the anti-gG3PD strongly stained
the plasma membrane of the parasite ventral surface likely
corresponding to the marginal groove and ventrolateral ﬂanges
(VLF), ﬁngerlike projections of the plasma membrane involved
in parasite attachment to the surface and to the host cell (Sousa
et al., 2001). As previously reported, the g14-3-3 showed a
spotty broad distribution in the parasite cell body, excluding the
nuclei and the median body (smile-like microtubule aggregate in
the middle of parasite body). The widespread g14-3-3 staining
makes it diﬃcult to claim for a discrete co-localization with the
gG3PD, although a slight co-localization signal (pseudo color
yellow) was visible at the posterior edge of the trophozoite
(Figure 1Ba, merge). G. duodenalis encystation was monitored
by the progressive appearance of specialized structures for the
secretion of the cyst wall proteins (CWP), the encysting speciﬁc
vesicles (ESVs), which were stained, together with the cyst wall,
by the anti-CWP mAb. In encysting parasites, in addition to the
ventral plasma membrane, the anti-gG3PD Ab (Figures 1Bb,c)
labeled several structures, similar to aggregates/small vesicles,
in the cytoplasm. These structures did not co-localize with the
ESVs and no straightforward co-localization with g14-3-3 could
be detected (Figures 1Bb,c). In cysts, the gG3PD was diﬀused in
the cytoplasm, although amarked aggregation close to the plasma
membrane, below the cyst wall was evident (Figure 1Bd). A faint
co-localization with g14-3-3 (pseudo color yellow) was detected
below the cyst wall.
Since the staining with the anti-gG3PD Ab observed in
encysting parasites resembled that of mitosomes, additional
co-localization experiments were performed using an antibody
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FIGURE 1 | Expression and localization of the glycerol-3-phosphate
dehydrogenase (gG3PD) during the differentiation stages of Giardia
duodenalis. (A) Western blot from three independent analysis of Triton
lysates (20 μg) from G. duodenalis WB-C6 trophozoites (T) and parasites
harvested at 6, 12, and 24 h after encystation induction. Immunoblotting
was performed with: anti-gG3PD polyclonal serum (α-gG3PD);
anti-phosphoacetylglucosamine mutase (α-PGM) (Lopez et al., 2003), to
follow the progression of encystation; the anti-α-tubulin (α-α-TUB), as loading
control. Molecular size markers (kDa) are reported on the left. The analysis is
representative of three independent experiments. (B) Confocal laser scanning
microscopy (CLSM) observations of fixed and permeabilized G. duodenalis
WB-C6 parasites at different stages: trophozoite (panel a, Trophozoite),
encysting parasite after 12 h of encystation (panel b and c, Encystation) and
cyst (panel d, Cyst) stained with the mouse polyclonal serum α-gG3PD (red)
and the α-g14-3-3 rabbit polyclonal (green). Cyst wall and encystation
specific vesicles (ESVs) were stained with Cy3-conjugated α-CWP mAb
(gray). Nuclei (N) were stained with 4′,6-diamidino-2-phenylindole (DAPI;
blue). Displayed micrographs correspond to a single z-stack: a and b, ventral
stacks; c and d, central stacks encompassing the nuclei. T, transmission light
acquisition. Scale bars, 5 μm. Arrows indicate the ventrolateral flanges (VLF).
A magnification (zoom) of the indicated area in the merged image is shown.
(C) CLSM observation as in (B). Parasites were stained with α-gG3PD (red)
and α-Tom40 antiserum (green; Dagley et al., 2009). Nuclei (N) were stained
with DAPI (blue). A magnification (zoom) of the indicated area in the merged
image is shown. Mitosomes are indicated (m). Images in (B) and (C) are
representative of >50 fields analyzed in two independent experiments.
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directed against the mitosomal marker Tom40 (Dagley et al.,
2009). As shown in Figures 1Ca,b, both in trophozoites
and encysting parasites, the anti-Tom40 Ab stained the main
central mitosome between the nuclei and several peripheral
smaller mitosomes. In trophozoites no co-localization with
anti-G3PD could be detected (Figure 1Ca), whereas in
encysting parasites superimposable signals (mean average
42 ± 6%; Figure 1Cb, pseudo color yellow) were mainly
evident in the peripheral mitosomes (mean average 27 ± 5%),
and to a lesser extent in the central one (mean average
2 ± 0.5%), suggesting a partial re-localization of the protein to
mitosomes.
Interaction between gG3PD and g14-3-3
To further characterize the gG3PD, a N-terminally FLAG-
HA tagged gG3PD was expressed in G. duodenalis under the
α-tubulin constitutive promoter. The FLAG-HA-gG3PD was
expressed at the same level, and comparable to the endogenous
protein, both in trophozoites and during the encystation
stage (Figure 2A) and the intracellular localization largely
resembled that of the endogenous gG3PD (Supplementary
Figure S2). By following protein fractionation (soluble and
membrane fractions), the endogenous and the FLAG-HA-
gG3PD were mainly detected in the soluble fraction at
both stages (Figure 2B). Whereas, a small protein amount
could be detected in the membrane fraction only at the
trophozoite stage (Figure 2B), partially in agreement with
immunolocalization observations, suggesting that the gG3PD
could form strong interactions with the membrane or with
membrane proteins. To better investigate the previously
suggested interaction between g14-3-3 and gG3PD (Lalle et al.,
2012), immunoprecipitation experiments were performed. As
shown by anti-HA immunoblotting (Figure 2C, upper), the
anti-FLAG mAb immunoprecipitated the FLAG-HA-gG3PD
only from transfected parasite extracts. Despite FLAG-HA-
gG3PD was comparably immunoprecipitated from both
trophozoites and encysting parasites, g14-3-3 was mainly co-
immunoprecipitated from trophozoites, whereas only a faint
signal was observed in the immunoprecipitate from encysting
parasites (Figure 2C, lower).
To shed light on the relevance of the two principal domains
characterizing the gG3PD protein, two deletion mutants were
constructed and independently expressed in G. duodenalis
as FLAG-HA-tagged proteins. The FLAG-HA-gG3PD_N
corresponds to N-terminal half of the protein (Supplementary
Figure S1A) and contains the FAD-dependent anaerobic
glycerol-3-phosphate dehydrogenase-like domain (residues
2–530); whereas the FLAG-HA-gG3PD_C corresponds to the
C-terminal half and contains the FAD-dependent pyridine
nucleotide-disulphide oxidoreductase-like domain (residues
524–1111). As shown by immunoblot (Figure 3A, upper and
middle), the expression of both FLAG-HA-tagged proteins
was detected at both stages. In all transfection experiments,
the expression of deletion mutants was lower than that of the
full-length FLAG-HA-gG3PD.
Intracellular localization of both mutants was performed
with anti-HA antibody. CLSM analyses (Figures 3Ba,b) showed
that, in trophozoites and encysting parasites, the FLAG-HA-
gG3PD_N partially localized to the ventral plasma membrane
and VLF, like the endogenous gG3PD. Although a spotty
cytoplasmic and an intense nuclear/perinuclear staining were
evident, in contrast with the endogenous and the full-length
FLAG-HA-gG3PD, suggesting that a fraction of the deleted
protein could be misfolded and/or mislocalized. In FLAG-
HA-gG3PD_C transgenic parasites the protein was completely
mislocalized and appeared widespread distributed, also inside
FIGURE 2 | Expression of the recombinant FLAG-HA-gG3PD in
G. duodenalis and its interaction with g14-3-3. (A) Western blot
analysis of Triton lysates from trophozoites (T) or parasites after 12 h of
encystation (E) obtained from FLAG-HA-gG3PD transfected line or from the
control WBC6 strain. Twenty-microgram of protein extracts were loaded in
each lane and separated on a 4–12% SDS-PAGE, then transferred on
nitrocellulose membrane and finally probed with the indicated antibodies.
Equal protein loading was monitored by anti-TUB Ab, whereas encystation
induction was confirmed by anti-gPGM Ab. Molecular size markers (kDa)
are reported in the left. (B) Subcellular distribution of gG3PD.
Thirty-microgram of fractionated protein lysate, soluble (S) or octyl
β-D-glucopyranoside solubilized membrane proteins (M), from trophozoites
(T) or 12 h encysting parasites (E) of FLAG-HA-gG3PD transfected
parasites or control WB-C6, were treated as described in (A) and probed
with the indicated antibodies. Molecular size markers are on the left.
(C) Co-immunoprecipitation assay of endogenous g14-3-3 with
FLAG-HA-gG3PD. An aliquot (1:5) of the FLAG peptide-eluted material
from WB-C6 or FLAG-HA-gG3PD transgenic line, deriving from trophozoites
(T) or encysting parasite (E), was separated on 4-12% SDS-PAGE and
immunoblotted with anti-HA (α-HA) or anti-g14-3-3 polyclonal serum
(α-g14-3-3). Molecular size markers are on the left. Immunoblots of (A–C)
are representative of three independent experiments.
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FIGURE 3 | Expression and intracellular localization of the
FLAG-HA-tagged gG3PD deletion mutants in G. duodenalis parasites.
(A) Representative western blot analysis of soluble protein lysate (20 μg)
from control WB-C6 and transgenic trophozoites (T) or parasites after 12 h
of encystation (E), expressing the full-length FLAG-HA-G3PD, or the
FLAG-HA-gG3PD_N or _C. Lysates were separated on 4–12% SDS-PAGE
and immunoblotted with the indicated antibodies. Arrows on the right
indicate the molecular size of the corresponding proteins. Molecular size
markers are on the left. The vertical line in the panel corresponding to the
α-HA blotting indicates two different times of exposure between the samples
of the same gel. The immunoblots are representative of three independent
experiments. (B) CLSM observations of fixed and permeabilized transgenic
G. duodenalis parasite expressing the FLAG-HA-gG3PD_N or the
FLAG-HA-gG3PD_C at different stages: trophozoite (panels a and d,
Trophozoite), encysting parasites after 12 h of encystation (panels b and e,
Encystation), and cysts (panels c and f, Cyst). Parasites were stained with
mouse α-HA mAb (green) and rabbit polyclonal α-g14-3-3 (red). Cyst wall
and encystation specific vesicles (ESVs) were stained by Cy3-conjugated
α-CWP mAb (gray). Nuclei were DAPI-stained (blue). Displayed micrographs
correspond to a single z-stack. T, transmission light acquisition. Scale bars
are reported. Arrows indicate the ventral plasma membrane and VLF. Images
are representative of >50 fields analyzed in two independent experiments.
nuclei, with the nuclear/perinuclear localization even more
evident in encysting parasites (Figures 3Bd,e). No mitosome-
like staining was observed in encysting parasites for any of the
mutants (Figures 3Bb,e). Few cysts with a spotty cytoplasmic
localization of the protein were observed in both transgenic
strains (Figures 3Bc,f). These observations likely suggest, that the
N-terminal half of the protein contains the structural/sequence
determiners necessary to localize the gG3PD at the ventral
plasma membrane and VLF. Looking for the domain(s) involved
in the interaction with g14-3-3, co-immunoprecipitation with
anti-FLAG was also performed using the FLAG-HA deletion
mutants. Despite several attempts no conclusive results were
obtained (data not shown), likely due to the low expression
of these proteins or to the presence of other factors that
could aﬀect the interaction (e.g., partial misfolding, incomplete
phosphorylation).
Evaluation of gG3PD Enzymatic Activity
To better deﬁne the role of gG3PD during G. duodenalis
diﬀerentiation, we ﬁrst characterized the protein activity using
N-terminally HIS-tagged versions of both full-length gG3PD
and deletion mutants heterologously expressed in E. coli. All
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FIGURE 4 | Evaluation of the gG3PD enzymatic activity.
(A) Spectrophotometric analysis of purified HIS-gG3PD. The UV-visible
spectrum of HIS-gG3PD (10 mg/ml) in 67 mM of potassium phosphate
buffer, pH 7.5, was recorded at 25◦C. The insert shows a magnification of
the HIS-gG3PD spectrum (solid line) in comparison with the spectrum of
authentic FAD (dotted line) recorded in the same buffer. Peak maxima are
reported. Spectra are representative of three independent experiments.
(B) Assessment of HIS-gG3PD dimerization in vitro. Purified recombinant
proteins (3 μmol) were separated on 3–12% Blue Native-PAGE and
silver-stained or transferred on polyvinylidene difluoride (PVDF) membrane
and probed with anti-HIS mAb. Native size markers (kDa) are indicated on
the left. Asterisks indicate HIS-gG3PD monomer (∗) or dimer (∗∗ ). Empty dots
indicate HIS-gG3PD_C monomer (◦) or dimer (◦◦). The arrow indicates
HIS-gG3PD_N monomer (<). Native-PAGE and immunoblot are
representative of three independent experiments. (C) The enzymatic activities
of both the purified HIS-gG3PD and the deletion mutant HIS-gG3PD_N were
measured in vitro, by MTT assay, in the presence (+FAD) or absence (no
FAD) of 10 μM FAD. The G3PD activity (mean ± SD) from three independent
experiments is expressed as nmol of reduced MTT per min per mg of
recombinant protein. Statistical analyses were performed using unpaired
t-test between the full length and the deletion mutant: ∗P < 0.05 and
∗∗P < 0.01. (D) The FAD-glycerol-3-phosphate dehydrogenase activity was
measured in protein extract (100 μg) from G. duodenalis trophozoites
(Trophozoite) or in parasite after 6 or 12 h from encystation induction
(Encystation). The relative enzymatic activity (mean ± SD) from three
independent experiments is expressed as the percentage change respect to
the value measured in trophozoites. Statistical analyses were performed
using unpaired t-test [Trophozoite vs. Encystation 6 h (∗∗P < 0.01) and
Trophozoite vs. Encystation 12 h (ns)], and one-way ANOVA (◦◦P < 0.001).
(E) Western blot analysis of protein extracts (20 μg) used to assay the
gG3PD enzymatic activity (as described in D), extracts were separated on
4–12% SDS-PAGE and immunoblotted with the indicated antibodies.
Molecular size markers are indicated on the left. Immunoblot is representative
of three independent experiments. (F) The intracellular glycerol content was
measured in supernatant from G. duodenalis trophozoites (Trophozoite) and
parasites after 6 or 12 h from encystation induction (Encystation). The relative
glycerol amount of three independent experiments (mean ± SD) is expressed
as the percentage change respect to the amount detected in trophozoites.
Statistical analyses were performed using unpaired t-test between Trophozite
and Encystation 6 h (∗∗∗P < 0.001) and Trophozite vs Encystation 12 h
(∗∗P < 0.01). One-way ANOVA confirmed that differences among groups
were statistically significant (◦◦P < 0.001).
recombinants were expressed as soluble proteins and could be
puriﬁed (up to 95%) under native conditions (Supplementary
Figure S3). The puriﬁed full-length HIS-gG3PD, but not the
deletion mutants, showed a distinctive yellow color (data not
shown), compatible with the presence of a ﬂavin cofactor. Indeed,
the UV-visible spectra of the HIS-gG3PD showed two absorbance
peaks with a maximum approximately at 350 and 440 nm
(Figure 4A), very close to those of free ﬂavin (either FAD or
FMN or both), supporting that the gG3PD is a ﬂavoprotein. No
similar peaks could be observed in the spectra of any deletion
mutants (data not shown). Since mG3PD/glpD are homodimeric
proteins (Mrácˇek et al., 2013), the dimeric nature of gG3PD was
assayed using native PAGE. As shown in Figure 4B, the HIS-
gG3PD_N was exclusively monomeric (60 kDa); whereas the
HIS-gG3PD migrated in the gel both as a 120 kDa monomer
and as a 240 kDa dimer, as conﬁrmed by immunoblot assay with
anti-HIS. Similarly, the HIS-gG3PD_C migrated as a monomer
around 60 kDa, and as a dimer of 120 kDa, thus suggesting that
at least one function of the gG3PD C-terminal half is to mediate
protein dimerization.
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The FAD-glycerol-3-phosphate dehydrogenase activity of the
HIS-gG3PD was then assayed by measuring the g3p-dependent
reduction of MTT in presence of PMS, which mediates
the transfer of reducing equivalent from the enzyme to the
terminal dye (Kistler and Lin, 1972). As shown in Figure 4C,
the HIS-gG3PD displayed a speciﬁc activity corresponding to
86.7 ± 5.6 nmol/min/mg in the absence of exogenous FAD,
that did not signiﬁcantly increase (89.8 ± 0.7 nmol/min/mg)
even when 10 μM FAD was added. Moreover, no activity
could be observed either in the absence of g3p or PMS
(data not shown), thus proving that g3p is indeed the
substrate of the enzyme and that an electron carrier molecule,
such as PMS, is required to reduce MTT. This is in
agreement with the role of quinone described for other
FAD-dependent G3PDs (Unden and Bongaerts, 1997; Mrácˇek
et al., 2013). Intriguingly (Figure 4C), the HIS-gG3PD_N,
containing the GlpA-like domain, also displayed a basal
enzymatic activity (30.5 ± 1.0 nmol/min/mg), 2.8-fold lower
in comparison with the full length protein, and it showed an
increase of 17% in the activity (36.7 ± 3.0 nmol/min/mg)
after stimulation with exogenous FAD. On the contrary,
the HIS-gG3PD_C did not show any enzymatic activity in
any condition (data not shown). These results support the
homology data and conﬁrm that the glycerol-3-phospate
dehydrogenase activity is localized to the N-terminal half of the
gG3PD.
To study the possible correlation between encystation-
dependent intracellular re-localization of gG3PD and its
function, the enzyme activity was measured in trophozoites and
encysting parasites extracts. Indeed, compared to trophozoites,
the gG3PD activity showed a 20% increase at 6 h of encystation
(Figure 4D), then it was reduced nearly down to the trophozoite
level after 12 h of encystation. No variation in the expression
level of the gG3PD protein could be observed at any time points
(Figure 4E). The encystation process in G. duodenalis has been
proposed as a primitive response to cellular stress (Argüello-
Garciá et al., 2009). In unicellular organisms, as response to
stress signals, the intracellular level of glycerol increases, as
consequence of a massive conversion of DAPH to g3p, due to the
greater activity of the NADPH-dependent G3PDs and in some
cases also to that of FAD-dependent G3PDs (Yang et al., 2007).
To test this hypothesis we measured the intracellular content of
glycerol during encystation. The amount of glycerol increased
up to 60% already at 6 h post-encystation induction (Figure 4F)
and then of an additional 15% in 12 h encysting parasites, thus
suggesting a possible relationship between the enhanced gG3PD
activity and the glycerol accumulation occurring during parasite
diﬀerentiation.
In Vivo Effects of NBDHEX on G. duodenalis
Survival and gG3PD Activity
Recently, a 7-nitro benzoxadiazole (NBD) derivative has been
shown to impair the growth of PC-3 adenocarcinoma cell
line by a signiﬁcant inhibition of the glycerol-3-phosphate
oxidoreductase activity of mG3PD (Singh, 2014). We wondered
whether this class of molecules could be eﬀective against
G. duodenalis trophozoites and the gG3PD. We selected the
NBDHEX, a promising antitumoral drug acting as a suicide
inhibitor of human glutathione S-transferases (GSTs), that also
shows a good tolerance in mouse models (Ricci et al., 2005;
Turella et al., 2005; Pellizzari Tregno et al., 2009; Tentori
et al., 2011). NBDHEX cytotoxicity against G. duodenalis
trophozoites was evaluated in vitro after 48 h of treatment in
microaerophilic growth conditions, using a colorimetric assay. As
shown (Figure 5A), NBDHEX was eﬀective against the parasite
(IC50: 0.3 ± 0.1 μM) at a lower concentration (5.6-fold) than
that of the reference drug MTZ (IC50: 1.5 ± 0.1 μM). Moreover,
under anaerobic growth conditions NBDHEX was also more
eﬀective than MTZ (IC50: 0.6 ± 0.4 μM for NBDHEX and
IC50: 1.9 ± 0.2 μM for MTZ; data not shown). To maximize
in a short time period the possible NBDHEX eﬀects, taking
into account the parasite intracellular environment, trophozoites
were treated in vivo with 50 μM NBDHEX and then the
gG3PD enzymatic activity was assayed in parasite extracts. A 50%
decrease of the gG3PD activity was already evident after 2 h of
treatment (Figure 5B, P < 0.01), and a further 5% decrease was
achieved after 4 and 6 h. This suggests that in vivo NBDHEX
treatment reduces the gG3PD activity, without inducing any
statistically relevant variation of the protein expression level
(Figure 5C).
Interaction of NBDHEX with gG3PD
To ascertain if the eﬀects on the gG3PD activity were due
to a direct NBDHEX binding to the enzyme, co-localization
experiments were performed by CLSM (Figure 6A), taking
advantage of the ﬂuorescent properties of the compound
(maximum emission peak at 525 nm; Ricci et al., 2005). Only
trophozoites treated with NBDHEX showed a spotted faint
ﬂuorescence in the cytoplasm. A more intense signal was
observed around the nuclei, in the areas corresponding to the
median body, in the intracellular portion of ventral ﬂagella and,
intriguingly, at the ventral plasma membrane. As shown, co-
localization signal (pseudo color yellow) between gG3PD and
NBDHEX was evident only at plasma membrane, without any
relevant alteration in the intracellular localization of gG3PD (for
comparison see Figures 1B,Ca). To further study the interaction
between NBDHEX and gG3PD, E. coli expressing the HIS-
gG3PD was incubated with NBDHEX, then the recombinant
protein was puriﬁed and, ﬁnally, the enzymatic activity was
assayed. Similar to the in vivo treatment of G. duodenalis with
NBDHEX, incubation of bacteria with the compound resulted
in a recombinant HIS-gG3PD having a 25% reduced enzymatic
activity (Figure 6B). Next, wewondered whether NBDHEXcould
bind HIS-gG3PD. We take advantage of the property of NBD
derivatives covalently bound to a protein to be visualized by
ﬂuorescence under ultraviolet (UV) light after SDS-PAGE (Bragg
and Hou, 1999). Indeed, HIS-gG3PD, puriﬁed from NBDHEX
treated bacteria, was ﬂuorescent under UV-light (Figure 6C,
right), even in the presence of a reducing agent (such as DTT).
On the contrary, no ﬂuorescence was associated with the HIS-
gG3PD puriﬁed from untreated bacteria. These results suggest
that NBDHEX strongly binds HIS-gG3PD. To conﬁrm this
hypothesis, puriﬁed HIS-gG3PD from bacteria, treated or not
with NBDHEX, was subjected to mass spectrometry analysis.
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FIGURE 5 | Evaluation of NBDHEX effects on G. duodenalis growth and
gG3PD enzymatic activity. (A) Survival of G. duodenalis WBC6 trophozoites
was determined by methylene blue colorimetric assay after 48 h of treatment
with different concentrations, ranging from 0.05 to 10 μM, of NBDHEX (empty
dots) or metronidazole (MTZ, empty squares) in microaerophilic growth
conditions. Data (mean percentage ± SD) represent three independent
experiments, each done in triplicate. The structure of the NBDHEX compound is
reported in the insert. (B) The FAD-glycerol-3-phosphate dehydrogenase activity
was measured in protein extract (100 μg) from G. duodenalis trophozoites
treated for the indicated times with 50 μM NBDHEX or for 6 h with ethanol
(Control). The enzymatic activity of three independent experiments (mean ± SD)
is expressed as the percentage change respect to the control. Unpaired t-test
was performed between control and each time point (∗P < 0.05 and
∗∗P < 0.01). One-way ANOVA indicated statistically significant differences
among all stages (◦◦◦P < 0.0001). (C) Twenty-microgram of protein extracts
derived from trophozoites treated as described in (B), were separated on
4–12% SDS-PAGE and immunoblotted. A representative western blot analysis is
shown and the antibodies indicated. Molecular size markers are reported in the
left. Table in the bottom reports the densitometric analysis of three independent
experiments (mean ± SD). Statistical analyses using t-test were not significant.
MS/MS spectra were acquired matching two HIS-gG3PD
peptides carrying NBDHEX derived adducts on cysteine residues:
the detected mass shift was compatible with an NBDHEX form
in which the nitro group was reduced to amine (Figure 6D).
No adduct with the intact NBDHEX moiety could be found,
probably because it was unstable or not detectable under the
applied experimental conditions. The presence of nitro-reduced
NBDHEX adducts was in favor of an electrochemical reduction
of the drug, likely by gG3PD. Therefore, NBDHEX properties
were evaluated by spectrophotometric and ﬂuorimetric analyses
after in vitro incubation with HIS-gG3PD. TheUV-visible spectra
of NBDHEX, incubated either with g3p or with HIS-gG3PD,
showed the typical peak centered around 430 nm (Figure 7A),
even after 80 min of incubation (data not shown). Incubation in
the presence of both HIS-gG3PD and g3p led to the progressive
decrease of the 430 nm absorption peak and to the appearance
of a less intense new one around 450–455 nm (Figure 7A). The
reaction was also associated with a change in color, from bright
yellow to brown (Figure 7B, insert) and the disappearance of the
525 nm emission peak of NBDHEX in the ﬂuorescence spectra
(Figure 7B). Since the amount of NBDHEX was in large excess
compared to HIS-gG3PD, the observed spectral alterations were
not imputable to binding of NBDHEX to the enzyme, but they
argued on NBDHEX modiﬁcation by the glycerol-3-phosphate
dehydrogenase activity of HIS-gG3PD. Such modiﬁcations could
be ascribable to a partial or complete reduction of the nitro group
to hydroxylamine or amine. Chemical reduction of the NBDHEX
nitro group to amine by sodium dithionite, proved by mass
spectrometry analysis (Supplementary Figure S4), resulted in the
decrease of the NBDHEX absorption peak at 430 nm, although
with the appearance of a new peak at 405 nm (Figure 7C), and
loss of ﬂuorescence too (Figure 7D). The observed diﬀerences
between UV-visible spectra of HIS-gG3PDand sodium dithionite
treatedNBDHEX suggest that the enzymatic activity produced an
optical species, probably compatible with an incomplete reduced
form of NBDHEX, carrying an hydroxylamine instead of an
amine moiety. On the other side, looking to the NBDHEX-
treated HIS-gG3PD, both in the presence or absence of g3p,
the enzyme resulted ﬂuorescent under UV light after SDS-
PAGE (Figure 7E). This suggests that protein adducts with
the unreduced NBDHEX occurred despite, enzyme activation.
Products from in vitro reactions between HIS-gG3PD and
NBDHEX were also analyzed by mass spectrometry. In the
sample incubated in the presence of g3p, some HIS-gG3PD
cysteine residues were modiﬁed by NBDHEX andMS/MS spectra
analysis allowed to detect mass shifts compatible with NBDHEX
adducts carrying the NO2 moiety completely reduced to NH2,
but also the semi-reduced hydroxylamine group (Supplementary
Figure S5). These adducts could not be detected when g3p was
omitted.
Since toxicity of the nitrocompound MTZ over G. duodenalis
has been related to its reduction to nitrosoimidazole or
hydroxylamine intermediate by ﬂavin enzymes (Leitsch et al.,
2007, 2009, 2011), we asked whether the gG3PD could be able
to nitroreduce MTZ. We then monitored variation in the MTZ
absorbance at 320 nm (Leitsch et al., 2011). As shown, no decrease
in MTZ absorbance occurred even after 80 min of incubation in
the presence of HIS-gG3PD and g3p (Figure 7F), thus suggesting
that in our experimental conditions MTZ is not nitroreduced by
gG3PD.
Discussion
In this work we have characterized, for the ﬁrst time, the FAD-
dependent glycerol-3-phosphate dehydrogenase of G. duodenalis
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FIGURE 6 | Interaction of NBDHEX with gG3PD. (A) CLSM analysis of fixed
and permeabilized G. duodenalis WBC6 trophozoites after 2 h incubation with
50 μM NBDHEX. NBDHEX (green) was directly visualized using the laser light at
488 nm ex. Parasites were stained with rabbit polyclonal anti-g14-3-3 and
AlexaFluor 647-conjugated anti-rabbit (red). Nuclei were stained with DAPI
(blue). Displayed micrographs correspond to a single z-stack. T, transmission
light acquisition. Scale bar is reported. Images are representative of >50 fields
analyzed in two independent experiments. (B) Histograms represent the
FAD-glycerol-3-phosphate dehydrogenase activity (mean percentage ± SD) of
recombinant HIS-gG3PD (16 pmol) purified from HIS-gG3PD-overproducing
E. coli after 2 h incubation with 50 μM NBDHEX (NBDHEX) or ethanol (Control).
The relative change in the enzymatic activity is given as percentage in relation to
the control. Statistical analyses were performed using unpaired t-test
(∗∗∗∗P < 0.0001) on three independent experiments. (C) SDS-PAGE (4–12%) of
2 μg of purified NBDHEX-treated (NBDHEX) or ethanol-treated (Control)
HIS-gG3PD, as described in (B), under reducing (+DTT) or not reducing
condition. On the left, gel stained with Coomassie blue; on the right, the same
gel photographed under UV light prior to staining. Molecular size markers are
indicated on the left. (D) MS/MS spectra matching the gG3PD peptides
(residues 539–551, left, and residues 859–872, right) carrying a mass increase
of 265 Da on the cysteine residues C545 and C865, respectively. The mass shift
is compatible with an NBDHEX-derived adduct in which the nitro group was
completely reduced to an amine. Data shown in (C) and (D) are representative
of three independent experiments.
both at molecular and functional level, and we have shown
that the antitumoral 7-NBD derivative NBDHEX displays a
remarkable antigiardial activity, targets the gG3PD and, when
in vivo administered to G. duodenalis, induces gG3PD activity
reduction.
The full length gG3PD has no orthologues in other organisms,
including humans, except for the diplomonad S. salmonicida
and the amebidae Entamoeba sp. The presence in the gram-
positive anaerobic actinobacteria Eggerthella sp. of an orthologue
of the ﬁrst 950 amino acids suggests that a ﬁrst gene fusion
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event between a GlpA-like gG3PD and a pyridine nucleotide-
disulphide oxidoreductase occurred in this prokaryotic lineage.
A lateral gene transfer (LGT) event could account for the
presence of this multi-domain protein both in G. duodenalis and
Entamoeba sp., that share with Eggerthella sp. the mammalian
intestine as ecological niche. LGT events have been already well
documented for genes of the anaerobic metabolism in eukaryotic
protozoan parasites such as Entamoeba histolytica, Trichomonas
vaginalis, and G. duodenalis (as well as in S. salmonicida;
Andersson et al., 2007;Morrison et al., 2007; Alsmark et al., 2009).
We demonstrate that the gG3PD is an active ﬂavoenzyme able
to use g3p as source of reducing equivalents. In agreement with
the domain topology and homology with bacterial GlpA subunit,
the enzymatic activity, as proven by deletion mutants, resides
in the N-terminal half of the protein. It is worth noting that
the modest stimulatory eﬀect exerted by additional FAD on the
enzymatic activity of both the gG3PD and the gG3PD_N, could
be explained by diﬀerent reasons (i) the full length gG3PD is
fully complexed with FAD; and/or (ii) the deletion mutant lacks
the ability to properly bind FAD; and/or (iii) the enzyme needs
FMN in addition to FAD. Indeed, the maximal activity of E. coli
trimeric GlpACB in vitro requires both FMN and FAD (Cole
et al., 1988), whereas glpD binds only FAD (Yeh et al., 2008).
Furthermore, we show that gG3PD is able to dimerize and that
the C-terminal half is required for the dimer formation. The
dimerization properties of this gG3PD region, absent in bacterial
GlpA, could be ascribable to its homology with members of the
FAD-dependent pyridine nucleotide-disulphide oxidoreductases,
a family of generally dimeric proteins (Argyrou and Blanchard,
2004).
Localization of the gG3PD to the ventral plasma membrane,
likely in correspondence to the VLF, and the detection of the
enzymatic activity in parasite extracts are in favor of the existence
of functional glycerol biosynthetic pathway and of a role of
the protein in G. duodenalis energy metabolism. Similar to
bacteria (Unden and Bongaerts, 1997), metabolization of g3p by
G. duodenalis could occur at plasma membrane via gG3PD thus
providing an extra source of DHAP for glycolysis and reducing
equivalents to putative ETCs. Experimental evidences indicate
that G. duodenalis can proliferate in vitro even in absence of
glucose, its main energy source (Adam, 2001), either in the
presence of serum (Schoﬁeld et al., 1991) or of a deﬁned mixture
of bile salts, phosphatidylcholine (PC) and cholesterol (Gillin
et al., 1986; Gault et al., 1987). Incorporation of free glycerol
and g3p in trophozoites has been reported to be negligible
(Jarroll et al., 1981). Nevertheless, mammalian bile and intestinal
epithelium mucus are rich of PC, that is eﬃciently taken up by
G. duodenalis trophozoites (Stevens et al., 1997). PC, in turns,
can potentially be converted to g3p by the combined activity of
a phospholipase PLB and a putative GPC-PDE, both encoded
by G. duodenalis genome (Morrison et al., 2007; Yichoy et al.,
2011).
We show that the gG3PD activity increases early at
encystation, without up-regulation of protein expression. In
this phase of encystation, energy metabolism and galactosamine
synthesis require extra carbon sources as consequence of
the highly reduced glucose uptake and decrease in oxygen
consumption (Paget et al., 1998). We may speculate that
gG3PD could provide extra carbon to glycolysis, via an
improved metabolization of g3p to DHAP. In parallel, we also
observed an increase in intracellular glycerol levels. In response
to stress conditions, including hyperosmotic stress, several
microorganisms synthesized glycerol as stress protector via an
increased DHAP to g3p conversion mediated by the NAD(P)H-
dependent G3PD (Albertyn et al., 1994; Yang et al., 2007; Chen
et al., 2012; Suescún-Bolívar and Thomé, 2015). The increase in
the bile salt, together with a slight alkaline pH, is a key encystation
signal eventually perceived by G. duodenalis as hyperosmotic
stress. It is worth to note that, in E. histolytica, intracellular
accumulation of both g3p and glycerol occurs in response to
oxidative stress despite only the gG3PD orthologue is present
and no NAD(P)H-dependent G3PD activity has been detected
(Husain et al., 2012). The unusual domain architecture of FAD-
dependent G3PDs from both G. duodenalis and E. histolyticamay
explained for a bi-directional activity of this enzymes A further
characterization of the gG3PD and a detailed metabolomics
analysis of the trophozoite and encystation stage of G. duodenalis
will be necessary to unravel any metabolic re-arrangement
occurring during the parasite diﬀerentiation and its link with
gG3PD activity.
The subcellular localization of gG3PD requires also other
considerations. The presence, only in trophozoites but not in
encysting parasites, of a fraction of the enzyme in the membrane
preparation is in agreement with the immunolocalization data
and suggests that gG3PD can associate with membranes in a stage
dependent-manner. The structural/sequence determinant(s)
responsible for the localization of the protein may reside in
the N-terminal half of gG3PD, as supported by the partial
localization of the gG3PD_N deletion mutant to the ventrolateral
side of the trophozoite. In addition, we conﬁrm that gG3PD and
g14-3-3 co-precipitate (this work; Lalle et al., 2012) mainly at
the trophozoite stage implying a role of the g14-3-3 in gG3PD
localization to ventral plasma membrane. The presence of several
putative mode-1 and mode-2 binding sites along the sequence of
gG3PD (Supplementary Figure S1; Lalle et al., 2012) can allow for
a direct interaction between the two proteins. Nevertheless, we
cannot exclude that the interaction between gG3PD and g14-3-3
is indirect and that both proteins are present in a multiprotein
complex, and further studies with diﬀerent deletion and point
mutants will clarify this issue. However, beyond the exact
interaction mechanism, a clear relationship between g14-3-3
and gG3PD localization and, possibly, its enzymatic activity, is
indicated by the strongly reduced co-precipitation of g14-3-3
with gG3PD during encystation and the partial re-localization of
gG3PD to mitosomes.
The re-localization of gG3PD to mitosomes, despite the
absence of any predictable mitochondrial targeting sequence
or cleavage site in the N-terminus, has been proved at least
for another G. duodenalis protein, namely GiiscS (Dolezal
et al., 2005). In our case, the lost of mitosomal localization
in both gG3PD deletion mutants suggests that targeting
to these organelles at least requires the full-length protein.
Although G. duodenalis mitosomes clearly miss the TCA
cycle and the typical ATP-generating mitochondrial respiratory
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FIGURE 7 | NBDHEX is substrate of HIS-gG3PD. (A) Spectrophotometric
analysis of the reaction between NBDHEX and gG3PD. The UV-visible spectrum
of NBDHEX (100 μM) in 67 mM potassium phosphate buffer (pH 7.5) was
recorded at 25◦C either in the presence of 17 mM g3p (red line, +g3p) or 80 nM
HIS-gG3PD (dashed black line, +HIS-gG3PD). The NBDHEX (100 μM)
UV-visible spectrum was also recorded at different time points (0, 10, 20, 40,
and 80 min) in the presence of both 17 mM g3p and 80 nM HIS-gG3PD
(+HIS-gG3PD+g3p). Arrows indicate the wavelength (nm) of the maximal
absorption. (B) Fluorescence spectra of 100 μM NBDHEX (excitation at
430 nm) after 80 min of incubation with 80 nM HIS-gG3PD, either in the
presence (solid line) or absence (dashed line) of 17 mM g3p. Fluorimetric
analyses were recorded at 25◦C in 67 mM potassium phosphate buffer (pH
7.5). NBDHEX fluorescence emission has a maximum peak wavelength at
525 nm. Fluorescence intensity (y axis) is arbitrary. The change in color of the
two reactions is shown in the insert. (C) The UV-visible spectrum of NBDHEX
(100 μM) in 67 mM potassium phosphate buffer (pH 7.5) was recorded at 25◦C
before (solid line) and after (dashed line) treatment with sodium dithionite
(Na2S2O4). The wavelengths (nm) of the maximal absorption are indicated with
arrows. (D) Fluorescence spectra of 100 μM NBDHEX (excitation at 430 nm)
before (solid line) and after Na2S2O4 (dashed line). The slight change in color of
the two conditions is shown in the insert. Spectra and images from (A–D) are
(Continued)
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FIGURE 7 | Continued
representative of three independent experiments. (E) SDS-PAGE (4–12%)
of 2 μg of HIS-gG3PD after 80 min of incubation at 25◦C with NBDHEX
(+NBDHEX) in the presence or not of g3p, or with ethanol (no NBDHEX). Gel
was photographed under UV light (UV, right) before staining with Coomassie
blue (Coomassie, left). Molecular size markers are reported in the left. Images
are representative of three independent experiments. (F) Comparison of the
UV-visible spectra of NBDHEX (green and orange line) or MTZ (solid and
dashed line) incubated with HIS-gG3PD and g3p (G3PD) at time 0 min and
after 80 min of incubation at 25◦C (T0 and T80, respectively). Arrows indicate
the wavelengths (nm) of the maximal absorption. Spectra are representative of
three independent experiments.
ETC (Han and Collins, 2012), the encystation-dependent
localization of gG3PD to mitosomes could be a reminiscence
of mitochondrial function of mG3PDs, where they participate
in the g3p shuttle and supply electrons to the mitochondria
ETC. A homolog of FAD-dependent mG3PD has been identiﬁed
also in the mitosomes of the microsporidia Antonospora
locustae, a group of spore-forming fungus-related intracellular
parasites (Dolgikh et al., 2011). The protein is expressed in
the spore and localizes in the mitosomes, where it channels
reducing equivalent to the so called alternative oxidase (Dolgikh
et al., 2011). Similarly, the presence of alternative ETCs in
G. duodenalis, as in the anaerobic bacteria respiration, cannot
be excluded (Unden and Bongaerts, 1997; Han and Collins,
2012). GiOR-1, a di-ﬂavoprotein able to reduce the gCYTb5-
IV and having ferredoxin-independent and NADPH-dependent
reductase activity, has been localized to the G. duodenalis
mitosome, suggesting that a NAD(P)-dependent ETC exists
in this organelle (Jedelský et al., 2011; Pyrih et al., 2014).
Similarly, the presence of a pyridine nucleotide-disulphide
oxidoreductase domain and of a putative metal binding
domain in gG3PD, both present in the ﬂavoprotein reductase
family (Argyrou and Blanchard, 2004), may imply that the
protein possesses a combined dehydrogenase and reductase
activity, although the ﬁnal acceptor, if any, is still to be
identiﬁed. Our results disclose a new perspective on the
role of mitosome in G. duodenalis suggesting that mitosomal
components and functions can change during the parasite
life cycle. Indeed, gG3PD was not detected in the proteome
of mitosomes isolated from trophozoites (Jedelský et al.,
2011).
Looking for compounds aﬀecting the gG3PD activity, we
demonstrate that the 7-NBD derivative NBDHEX, a patented
anti-tumor drug (Ricci et al., 2005; Turella et al., 2005), exerts
cytotoxic activity toward G. duodenalis trophozoites and, when
administered in vivo, hampers the g3p dehydrogenase activity of
gG3PD. The IC50 of NBDHEX is twofold to ﬁvefold lower than
MTZ, proving that the compound is more eﬀective in killing
G. duodenalis than the reference drug, even in microaerobic
conditions. This indicates that the presence of O2 does not
produce opposite eﬀects on NBDHEX, as on the contrary occurs
for re-oxidation of MTZ nitroradical anions. G. duodenalis
is a microaerophilic parasite that lives in the fairly aerobic
(up to 60 μM O2) environment of the upper intestine, so
that a drug potentially eﬀective also in presence of O2 is
more attractive for therapeutic use. We show that NBDHEX
binds to gG3PD, when administered both in vivo and in vitro.
NBDHEX is an excellent electrophile that can easily form
σ-complexes, as occurs between glutathione and the C-4 position
of the drug in the G-site of GST, leading to the inhibition of
the detoxifying and anti-apoptotic activity of human GSTP1-
1 (Ricci et al., 2005; Federici et al., 2009). Since no gene
coding for GST is present in G. duodenalis (Morrison et al.,
2007), we can bona fide exclude that antigiardial activity of
NBDHEX may be due to any GST inhibition, although a low
level of GSH has been detected (Krauth-Siegel and Leroux,
2012). The formation of σ-complexes likely occurs between
NBDHEX and gG3PD, as suggested by in gel ﬂuorescence
of gG3PD after NBDHEX treatment, but, unfortunately, our
attempts to identify these complexes by mass spectrometry were
unsuccessful. Furthermore, we demonstrate the occurrence of
NBDHEX covalent adducts at several gG3PD cysteine residues,
with the 7-nitro group of the drug being reduced either
completely to amine or partially to hydroxylamine. Diﬀerent
NBDHEX modiﬁed cysteine residues of His-gG3PD were found
in diﬀerent experimental conditions, i.e., NBDHEX treatment
in E. coli or in vitro, likely as the result of a diﬀerential
accessibility of the drug to such residues. Our in vitro assays
and MS data indicate that the nitro reduced NBDHEX adducts
derive from the gG3PD-mediated electrochemical reduction
of the drug, possibly via the formation of highly reactive
intermediates, such as nitroso or hydroxylamine radicals. It is
well known that during the FAD-mG3PD-mediated oxidation
of the 2-hydroxy group of g3p, to form DHAP, two electrons
are transferred to FAD and then to the quinone pool (Mrácˇek
et al., 2013). Similarly, gG3PD activity can generate two
electrons able to reduce the nitro group to a hydroxylamine
intermediate. Enzymatic reduction has also been proposed
as a mechanism for the activation of nitrocompounds, i.e.,
MTZ, leading to protein covalent adducts formation and
cytotoxicity in several microaerophilic protozoan parasites. In
particular, the ﬂavoprotein TRxR can nitroreduce MTZ, by
a process involving its ﬂavin cofactor, thus forming covalent
adducts with the drug (Leitsch et al., 2007, 2009, 2011).
Remarkably, although gG3PD displays nitroreductase activity
toward NBDHEX, no nitroreduction of MTZ could be observed
in our experimental conditions. Nitroimidazoles and other
nitrocompounds seem to be metabolized in G. duodenalis in
a diﬀerent manner, also in comparison to E. histolytica and
T. vaginalis, and protein adducts can be formed only with
some of these drugs (Leitsch et al., 2012). Indeed, gG3PD was
not identiﬁed among the proteins forming adducts with MTZ
or tinidazole neither in G. duodenalis nor in E. histolytica
(Leitsch et al., 2007, 2012). In particular, these diﬀerences
in nitrocompound metabolization have been related to the
adaptation of G. duodenalis to rather high concentrations
of O2 in the upper small intestine. We can speculate that
gG3PD-mediated NBDHEX nitroreduction may be inﬂuenced
by a redox-cycling property of 7-NBD derivative in presence
of O2. NBF-SPh, a compound related to NBDHEX, has a
redox-cycling activity with nitro group cycling to nitroso and
hydroxylamine intermediates by reversible electron transfer to
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O2 before becoming exhausted and ﬁnally reduced to amine
(Patridge et al., 2012). During redox-cycling, NBF-SPh rapidly
converts O2 to ROS at an higher rate than that of the most
toxic redox-cycling quinones and the nitrocompound MTZ.
Bio-reduction of the redox cycling naphthoquinone menadione
by ﬂavoprotein/iron–sulphur-mediated electron transfer in both
G. duodenalis trophozoites and cysts has been proven to be a
potent generator of ROS, even in the presence of low levels
of oxygen, thus leading to parasite killing (Paget et al., 2004).
Therefore, we propose that the cytotoxicity exerted by NBDHEX
against G. duodenalis could be due to its nitroreduction and to
ROS generation during the reductive process, likely involving
gG3PD. Finally, it should be considered that nitroreduction of
NBDHEX, at least in part mediated by gG3PD, could subtract
electrons from their physiological acceptor(s) thus altering the
G. duodenalis intracellular redox metabolism.
Although further studies are necessary to fully understand
the metabolic pathways involving the gG3PD, as well as the
mechanisms of the enzyme regulation in G. duodenalis, we
have clearly proven, for the ﬁrst time, that a functional FAD-
dependent gG3PDworks inG. duodenalis and could be a valuable
potential candidate for the design of novel antigiardial drugs
having NBDHEX, a representative of novel class of antitumoral
molecules, as leading compound.
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